Atlas Trials

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine

Clinical trial NCT04497298 · COMPLETED

Trial details

NCT number
NCT04497298
Sponsor
Institut Pasteur
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-08-10
Primary completion
2021-05-12
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.